| Description | Remlarsen (MRG-201), a miR-29b mimic, functions as a miR-29b agonist with the potential to prevent the formation of fibrotic scars or cutaneous fibrosis. |
| In vitro | Remlarsen (MRG-201) is active in regulating PD biomarker expression in the skin[1]. |
| Synonyms | MRG-201 |
| molecular weight | N/A |
| CAS | 1848266-71-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Corrie L Gallant-Behm, et al. A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin. J Invest Dermatol. 2019 May;139(5):1073-1081. |